Effectiveness and cost-effectiveness of meaning-centered group psychotherapy in cancer survivors: protocol of a randomized controlled trial

详细信息    查看全文

• 作者：Nadia van der Spek (1)
  Jo?l Vos (2) (3)
  Cornelia F van Uden-Kraan (1) (4)
  William Breitbart (5)
  Pim Cuijpers (1)
  Kitty Knipscheer-Kuipers (6)
  Vincent Willemsen (6)
  Rob AEM Tollenaar (7)
  Christi J van Asperen (3)
  Irma M Verdonck-de Leeuw (1) (4)
  
• 关键词：Cancer ; Survivorship ; Meaning ; Psycho ; oncology ; Existential distress ; Group psychotherapy ; Effectiveness ; Cost ; effectiveness
• 刊名：BMC Psychiatry
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：14
• 期：1
• 全文大小：292 KB
• 参考文献：1. Brenner H: Long-term survival rates of cancer patients achieved by the end of 20th century: a period analysis. / Lancet 2002, 360:1131-135. CrossRef
  2. Richards M, Stockton D, Bapp P, Coleman MP: How many deaths have been avoided through improvements in cancer survival? / Brit Med Journal 2000, 320:895-98. CrossRef
  3. Lee V: The existential plight of cancer: meaning making as a concrete approach to the intangible search for meaning. / Support Care Cancer 2008, 16:779-85. CrossRef
  4. Tomich PL, Helgeson VS: Five years later: a cross-sectional comparison of breast cancer survivors with healthy women. / Psychooncology 2002, 11:154-69. CrossRef
  5. Zika S, Chaimberlain K: On the relation between meaning in life and well-being. / Br J Psychol 1992, 83:133-45. CrossRef
  6. Debats DL: Meaning in life: clinical relevance and predictive power. / Brit J of Clin Psychol 1996, 35:503-16. CrossRef
  7. Park CL, Edomondson D, Fenster JR, Blank TO: Meaning making and psychological adjustment following cancer: the mediating roles of growth, life meaning, and restored just-world beliefs. / Cons and Clin Psy 2008, 76:863-75. CrossRef
  8. Lee V, Cohen SR, Edgar L, Laizner AM, Gagnon AJ: Meaning-making intervention during breast or colorectal cancer treatment improves self-esteem, optimism, and self-efficacy. / Soc Sci Med 2006, 62:3133-145. CrossRef
  9. Chochinov HM, Hack TF, Hassard T, Kristjanson LJ, McClement S, Harlos M: Dignity therapy: a novel psychotherapeutic intervention for patients near the end of life. / J Clin Oncol 2005, 23:5520-525. CrossRef
  10. Giese-Davis J, Koopman C, Butler LD, Classen C, Cordova M, Fobair D, Benson J, Kraemer HC, Spiegel D: Change in emotion-regulation strategy for women with metastatic breast cancer following supportive-expressive group therapy. / Cons and Clin Psy 2002, 70:916-25. CrossRef
  11. Breitbart W, Rosenfeld B, Gibson C, Pessin H, Poppito S, Nelson C, Tomarken A, Kosinski Timm A, Berg A, Jacobson C, Sorger B, Abbey J, Olden M: Meaning-centered group psychotherapy for patients with advanced cancer: a pilot randomized controlled trial. / Psychooncology 2010, 19:21-8. CrossRef
  12. Classen C, Butler LD, Koopman C, Miller E, DiMiceli S, Giese-Davis J, Fobair P, Carlson RW, Kraemer HC, Spiegel D: Supportive-expressive group therapy and distress in patients with metastatic breast cancer. / Arch of Gen Psychiatry 2001, 28:494-01. CrossRef
  13. Spiegel D, Spira J: / Supportive-Expressive Group Therapy: A Treatment Manual of Psychosocial Intervention for Women with Recurrent Breast Cancer. Stanford, CA: Stanford University School of Medicine; 1991.
  14. Kissane DW, Bloch S, Smith GC, Miach P, Clarke DM, Ikin J, Love A, Ranieri N, McKenzie D: Cognitive-existential group psychotherapy for women with primary breast cancer: a randomised controlled trial. / Psychooncology 2003, 12:532-46. CrossRef
  15. Coward DD: Facilitation of self-transcendence in a breast cancer support group: II. / Onc Nurs Forum 2003, 30:291-00. CrossRef
  16. LeMay K, Wilson KG: Treatment of existential distress in life threatening illness: a review of manualized interventions. / Clin Psychol Rev 2008, 28:472-93. CrossRef
  17. Linn M, Linn B, Harris R: Effects of counseling for late-stage cancer patients. / Cancer 1982, 49:1048-055. CrossRef
  18. Breitbart W: Spirituality and meaning in supportive care: spirituality- and meaning-centered group psychotherapy interventions in advanced cancer. / Support Care Cancer 2002, 10:272-80. CrossRef
  19. Frankl V: The doctor and the soul. In / From Psychotherapy to Logotherapy. London: Random House; 1986.
  20. Frankl V: / The Will to Meaning: Foundations and Applications of Logotherapy, ed. L. New York: New American; 1989.
  21. Frankl V: / Man’s Search for Meaning: An Introduction to Logotherapy. London: British paperback edition: random House; 1998.
  22. Van der Spek N, Vos J, Van Uden-Kraan CF, Breitbart W, Tollenaar RAEM, Cuijpers P, Verdonck-de Leeuw IM: Meaning making in cancer survivors: a focus group study. / PLoS One 2013, 8:1-. CrossRef
  23. Van der Spek N, Van Uden-Kraan CF, Vos J, Breitbart W, Tollenaar RAEM, Van Asperen CJ, Cuijpers P, Verdonck-de Leeuw IM: Meaning-Centered Group Psychotherapy in Cancer Survivors: a Feasibility Study . / Psychooncology 2014. DOI: 10.1002/pon.3497 [E pub ahead of print]
  24. Payne DK, Vroom P, Phil M: / Supportive Group Psychotherapy: A Group Intervention for Cancer Patients. Memorial Sloan-Kettering Cancer Center: New York; 2009.
  25. Jaarsma TA, Pool G, Ranchor AV, Sanderman R: The concept and measurement of meaning in life in Dutch cancer patients. / Psychooncology 2007, 16:241-48. CrossRef
  26. Jaarsma TA, Pool G: / Posttraumatic Growth Inventory: Dutch Version. Groningen: Noordelijk Centrum voor Gezondheidsvraagstukken; 2003.
  27. Dierendonck D: The construct validity of Ryff’s scales of psychological well-being and its extension with spiritual well-being. / Pers Individ Dif 2005, 36:629-43. CrossRef
  28. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. / J Natl Cancer Inst 1993, 85:365-76. CrossRef
  29. Fayers P, Bottomley A: Quality of life research within the EORTC-the EORTC QLQ - C30, European Organisation for Research and Treatment of Cancer. / Eur J Cancer 2002, 38:125-33. CrossRef
  30. Spinhoven P: A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. / Psychol Med 1997, 27:363-70. CrossRef
  31. Young MA, Halper IS, Clark DS, Scheftner W, Fawcett J: An item-response theory evaluation of the Beck Hopelessness Scale. / Cog Ther Res 1992, 16:579-87. CrossRef
  32. Beck AT, Weissman A, Lester D, Trexler L: Measurement of pessismism- hopelessness scale. / Cons and Clin Psy 1974, 42:861-65. CrossRef
  33. Scheier MF, Carver CS, Bridges MW: Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem) - a reevaluation of the life orientation test. / J Pers Soc Psychol 1994, 67:1063-078. CrossRef
  34. ten Klooster PM, Weekers AM, Eggelmeijer F, Van Woerkom JM, Drossaert CHCM, Taal E, Rasker JJ, Baneke JJ: Optimisme en/of pessimisme: factorstructuur van de Nederlandse Life Orientation Test-Revised. / Psychologie en Gezondheid 2010, 38:89-00. CrossRef
  35. Van Roijen L, Van Straten A, Maiwenn AL, Rutten F, Donker M: Cost-utility of brief psychological treatment for depression and anxiety. / Br J Psychiatry 2006, 188:323-29. CrossRef
  36. Oostenbrink JB, Bouwmans CAM, Koopmanschap MA: / Manual for Costing: Methods and Standard Costs for Economic Evaluations in Health Care. Diemen: Health Insurance Board; 2004.
  37. Brooks R: EuroQol: the current state of play. / Health Pol 1996, 37:53-2. CrossRef
  38. Koopmanschap MA: PRODISQ: a modular questionnaire on productivity and disease for economic evaluation studies. / Expert Rev Pharmacoecon Outcomes Res 2005, 5:23-8. CrossRef
  39. Preacher KJ, Hayes AF: Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. / Behav Res Methods 2008, 40:879-89. CrossRef
  40. Kraemer HC, Wilson T, Fairburn CG, Phil M, Agras S: Mediators and moderators of treatment effects in randomized clinical trials. / Arch of Gen Psychiatry 2002, 59:877-83. CrossRef
  41. Oostenbrink JB: Standardisation of costs: the Dutch Manual for Costing in economic evaluations. / Pharmacoeconomics 2002, 20:443-54. CrossRef
  42. Langley PC: The November 1995 revised Australian guidelines for the economic evaluation of pharmaceuticals. / Pharmacoeconomics 1996, 9:341-52. CrossRef
  43. Torrance GW, Blaker D, Detsky A, Kennedy W, Schubert F, Menon D, Tugwell P, Konchak R, Hubbard E, Fireston T: Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics. / Pharmacoeconomics 1996, 9:535-59. CrossRef
  44. Brouwer WB, Koopmanschap MA, Rutten FF: Productivity losses without absence: measurement validation and empirical evidence. / Health Pol 1999, 48:13-7. CrossRef
  45. Van Hout BA, Maiwenn JA, Gordon GS, Rutten FFH: Costs, effects and C/E-ratios alongside a clinical trial. / Health Econ 1994, 3:309-19. CrossRef
  46. Thompson SC, Pitts J: Factors relating to a person’s ability to find meaning after a diagnosis of cancer. / J Psychosoc Oncol 1994, 11:1-1. CrossRef
  47. Gottlieb BH, Wachala ED: Cancer support groups: a critical review of empirical studies. / Psychooncology 2006, 16:379-00. CrossRef
  48. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-244X/14/22/prepub
  
• 作者单位：Nadia van der Spek (1)
  Jo?l Vos (2) (3)
  Cornelia F van Uden-Kraan (1) (4)
  William Breitbart (5)
  Pim Cuijpers (1)
  Kitty Knipscheer-Kuipers (6)
  Vincent Willemsen (6)
  Rob AEM Tollenaar (7)
  Christi J van Asperen (3)
  Irma M Verdonck-de Leeuw (1) (4)
  
  1. Department of Clinical Psychology, VU University, VdBoechorststraat 1, room 2B-64, Amsterdam, 1081 BT, The Netherlands
  2. Department of Psychology, University of Roehampton, London, UK
  3. Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands
  4. Department of Otolaryngology - Head & Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands
  5. Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, USA
  6. Ingeborg Douwes Centrum, Center for psychological care for cancer patients, Amsterdam, The Netherlands
  7. Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands
  
• ISSN：1471-244X

文摘

Background Meaning-focused coping may be at the core of adequate adjustment to life after cancer. Cancer survivors who experience their life as meaningful are better adjusted, have better quality of life and psychological functioning. Meaning-Centered Group Psychotherapy for Cancer Survivors (MCGP-CS) was designed to help patients to sustain or enhance a sense of meaning and purpose in their lives. The aim of the proposed study is to evaluate the effectiveness and cost-effectiveness of MCGP-CS. Methods/Design Survivors diagnosed with cancer in the last 5 years and treated with curative intent, are recruited via several hospitals in the Netherlands. After screening, 168 survivors are randomly assigned to one of the three study arms: 1. Meaning-Centered Group Psychotherapy (MCGP-CS) 2. Supportive group psychotherapy (SGP) 3. Care as usual (CAU). Baseline assessment takes place before randomisation, with follow up assessments post-intervention and at 3, 6 and 12 months follow-up. Primary outcome is meaning making (PMP, PTGI, SPWB). Secondary outcome measures address quality of life (EORTC-30), anxiety and depression (HADS), hopelessness (BHS), optimism (LOT-R), adjustment to cancer (MAC), and costs (TIC-P, EQ-5D, PRODISQ). Discussion Meaning-focused coping is key to adjustment to life after cancer, however, there is a lack of evidence based psychological interventions in this area. Many cancer survivors experience feelings of loneliness and alienation, and have a need for peer support, therefore a group method in particular, can be beneficial for sustaining or enhancing a sense of meaning. If this MCGP-CS is effective for cancer survivors, it can be implemented in the practice of psycho-oncology care. Trial registration Netherlands Trial Register, NTR3571